| Authors: |
Gustine JN; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Branagan AR; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Cirstea DD; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Rexha F; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Han R; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Yee AJ; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Maus MV; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Frigault MJ; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA., Raje NS; Division of Hematology and Oncology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA. |
